Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:626-628
Published online before print January 22, 2008, doi: 10.1161/HYPERTENSIONAHA.107.104133
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/3/626    most recent
HYPERTENSIONAHA.107.104133v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jalil, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jalil, J. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-SERINE
*NITRIC OXIDE
Related Collections
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology
Right arrowRelated Article

(Hypertension. 2008;51:626.)
© 2008 American Heart Association, Inc.


Editorial Commentaries

Blood Pressure Reduction, Potassium Channels, and the Endothelium

Insights From L-Serine

Jorge E. Jalil

From the Pontificia Universidad Católica de Chile, Department of Cardiovascular Diseases, Laboratory of Mollecular Cardiology, Santiago, Chile.

Correspondence to Jorge E. Jalil, Pontificia Universidad Católica de Chile, Department of Cardiovascular Diseases, Laboratory of Mollecular Cardiology, Lira 85 Piso 2, Santiago, Chile. E-mail jjalil@med.puc.cl


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

In this issue of Hypertension, Mishra et al1 compared the in vitro effects of the amino acid L-serine, a precursor of central neurotransmitters, and acetylcholine in phenylephrine-constricted mesenteric arterioles in NG-nitro-L-arginine methyl ester (L-NAME)-pretreated hypertensive rats, as well as in normotensive rats.1 L-Serine evoked concentration-dependent vasodilatation in endothelium-intact but not in endothelium-denuded vessels. This response to L-serine was abolished by a combination of apamin (a small conductance Ca2+-activated K+ channel inhibitor) and TRAM-34 (an intermediate conductance Ca2+-activated K+ channel inhibitor), ouabain (Na+ pump inhibitor) and barium chloride (an inward-rectifier K+ channel inhibitor), or when the vessels were constricted by potassium chloride.

In addition, the authors determined in vivo changes in mean arterial blood pressure and heart rate induced by acute intravenous infusion of either L-serine or acetylcholine in anesthetized rats. The maximal response to L-serine was higher in the L-NAME treatment group in contrast to the maximal response to acetylcholine. L-Serine evoked a rapid, reversible, dose-dependent fall in mean arterial pressure without increasing heart rate, which was more pronounced in L-NAME-treated hypertensive rats than in the control rats. This acute hypotensive effect of L-serine was significantly inhibited by apamin and charybdotoxin pretreatment, a combination that blocks Ca-activated K channels or endothelium-derived hyperpolarizing factor (EDHF).

The authors discussed that the acute dose-dependent response to L-serine may be because of activation of vascular/endothelial KCa channels (exaggerated when the NO system is blunted in the . . . [Full Text of this Article]


Related Article:

Nitric Oxide Synthase Inhibition Promotes Endothelium-Dependent Vasodilatation and the Antihypertensive Effect of L-Serine
Ramesh C. Mishra, Saswati Tripathy, Kaushik M. Desai, Dale Quest, Yanjie Lu, Jawed Akhtar, and Venkat Gopalakrishnan
Hypertension 2008 51: 791-796. [Abstract] [Full Text] [PDF]